Text Classification on Drug Review Norethindrone (5-fold cross-validation)
60AccuracyDALTA
Evaluation results
| Method | Links | |
|---|---|---|
| DALTAk=10, classifier=LR2025.06 | 60 | |
| DALTAk=20, classifier=LR2025.06 | 60 | |
| DALTAk=10, classifier=SVC2025.06 | 59.8 | |
| DALTAk=20, classifier=SVC2025.06 | 59.8 | |
| ECRTMk=10, classifier=LR2025.06 | 59.6 | |
| ECRTMk=20, classifier=SVC2025.06 | 59.2 | |
| ProdLDAk=10, classifier=SVC2025.06 | 58.7 | |
| CTMk=20, classifier=SVC2025.06 | 58.6 | |
| ECRTMk=10, classifier=SVC2025.06 | 58.4 | |
| Fastopick=20, classifier=LR2025.06 | 58.4 | |
| Fastopick=10, classifier=LR2025.06 | 58.2 | |
| LDAk=20, classifier=LR2025.06 | 57.8 | |
| CTMk=20, classifier=LR2025.06 | 57.6 | |
| Fastopick=20, classifier=SVC2025.06 | 57.2 | |
| ProdLDAk=20, classifier=SVC2025.06 | 57 | |
| ProdLDAk=10, classifier=LR2025.06 | 56.9 | |
| CTMk=10, classifier=SVC2025.06 | 56.6 | |
| LDAk=10, classifier=SVC2025.06 | 56.4 | |
| LDAk=10, classifier=LR2025.06 | 56.4 | |
| Fastopick=10, classifier=SVC2025.06 | 56.4 | |
| LDAk=20, classifier=SVC2025.06 | 56.2 | |
| Meta-CETMk=20, classifier=LR2025.06 | 56.1 | |
| Meta-CETMk=10, classifier=SVC2025.06 | 55.8 | |
| CTMk=10, classifier=LR2025.06 | 55.2 | |
| ECRTMk=20, classifier=LR2025.06 | 55.2 | |
| Meta-CETMk=20, classifier=SVC2025.06 | 54.3 | |
| ProdLDAk=20, classifier=LR2025.06 | 54 | |
| Meta-CETMk=10, classifier=LR2025.06 | 51.9 | |
| DeTimek=10, classifier=SVC2025.06 | 46.4 | |
| DeTimek=10, classifier=LR2025.06 | 46.4 | |
| DeTimek=20, classifier=SVC2025.06 | 46.4 | |
| DeTimek=20, classifier=LR2025.06 | 46.4 | |
| ETMk=10, classifier=LR2025.06 | 45.2 | |
| ETMk=10, classifier=SVC2025.06 | 45.1 | |
| ETMk=20, classifier=LR2025.06 | 44.2 | |
| ETMk=20, classifier=SVC2025.06 | 43.3 |